NINTEDANIB ESYLATE vs NIRAPARIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NINTEDANIB ESYLATE vs NIRAPARIB: Safety Overview
| Metric | NINTEDANIB ESYLATE | NIRAPARIB |
|---|---|---|
| Total FAERS Reports | 117 | 21,634 |
| Deaths Reported | 23 | 1,370 |
| Death Rate | 19.7% | 6.3% |
| Hospitalizations | 39 | 4,892 |
| Average Patient Age | 66.4 yrs | 65.7 yrs |
| % Female Patients | 47.8% | 98.5% |
| FDA Approval Date | Oct 15, 2014 | Apr 26, 2023 |
| Manufacturer | Boehringer Ingelheim Pharmaceuticals,... | GlaxoSmithKline LLC |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Discontinued |